Contact – +1-276-477-5910
 Email – [email protected]

Home >>

Healthcare

>>

Global Amyotrophic Lateral Sclerosis Treatment Market


Global Amyotrophic Lateral Sclerosis Treatment Market by Treatment (Medication, Stem Cell Transplant), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies) - Market Research Report 2021 : Covid 19 Impact Outlook, Regional Analysis, Competitive Landscape, Growth Prospects & Forecast 2020-2026

Report code: SDMRHE1564980 | Industry: Healthcare | Published On: 1/1/2021


Global Amyotrophic Lateral Sclerosis Treatment Market Size, Share & Trends Analysis Report by Treatment (Medication, Stem Cell Transplant), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies) - Global Forecast to 2026
Global Amyotrophic Lateral Sclerosis Treatment Market is valued at 576.34 USD Million in 2019 and expected to reach USD 885.00 Million by 2026 with the CAGR of 6.3% over the forecast period.

Scope of the report
This report analyses the global market for Amyotrophic Lateral Sclerosis Treatment. The report will enable the user to understand and gain insights into the current and forecast market situation. The market is comprehensively analyzed by geography to give complete information on the global scenario. The qualitative and quantitative data provided in this study can help user understand which market segments, regions are expected to grow at higher rates, factors affecting the market and key opportunity areas. The report also includes competitive landscape of key players in the industry along with emerging trends in the market.

Key Players
Mitsubishi Tanabe Pharma Corporation, Otsuka Pharmaceutical Co., Ltd., BrainStorm Therapeutics, Biogen Inc., Corestem, AB Science, F.Hoffmann-La Roche AG, Biohaven Pharmaceutical, Sun Pharmaceutical, Ionis Pharmaceuticals, Inc. Mitsubishi Tanabe Pharma Corporation and others
Above mentioned companies were scrutinized to assess competitive landscape of global Amyotrophic Lateral Sclerosis Treatment market. Report provides company profiles of each player. Each profile include company product portfolio,business overview, company governance, company financials, business strategies, manufacturing locations and production facilities, company sale, recent developments and strategic collaborations & partnerships, new product launch, company segments, application diversification and company strength and weakness analysis.


Review period:
(2016-2026)
Historic Period: 2016 to 2019
Forecast Period: 2020 to 2026
Base Year: 2019
Unit: USD Million
This Amyotrophic Lateral Sclerosis Treatment market report provides insights on new trade regulations, import export analysis, industry value chain analysis, market size, consumption, production analysis, capacity analysis, regional and segment market share, product launches, product pipeline analysis, impact of Covid-19 on supply chain, key regions, untapped markets, patent analysis, product approvals, continuous innovations and developments in the market.



Regions


• North America: U.S., Canada and Rest of North America
• Europe: UK, France, Germany, Italy, Spain and Rest of Europe
• Asia Pacific: China, Japan, India, Australia, Southeast Asia and Rest of Asia Pacific
• Latin America: Brazil, Mexico, Argentina and Rest of Latin America
• Middle East and Africa: Gulf Countries, Israel, Africa and Rest of Middle East and Africa

Market Segmentation



Treatment
• Medication
• Stem Cell Therapy
• Others
Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Others



Report Coverage

• An overview of the global Amyotrophic Lateral Sclerosis Treatment market
• In depth analysis of market dynamics and major factors such as drivers, restraints, opportunities and trends influencing the global market
• Global Amyotrophic Lateral Sclerosis Treatment market revenue data historic and forecast analysis (2016 to 2026)
• Characterization and quantification of the market segments for Amyotrophic Lateral Sclerosis Treatment market
• Market share analysis of key market participants and their competitive landscape

Important Questions Answered by Global Amyotrophic Lateral Sclerosis Treatment Market Report
• What is the impact of COVID 19 epidemic on the global Amyotrophic Lateral Sclerosis Treatment market?
• Which is mostly affected region, country?
• Which is the current largest and fastest-growing region?
• What is the market size and growth rate of the global Amyotrophic Lateral Sclerosis Treatment market?
• What are current factors affecting the growth of market?
• What are Key trends and opportunity areas?
• Within Amyotrophic Lateral Sclerosis Treatment market, which segments are fastest growing & emerging strongly? What are the drivers and restraints for each segment? What are vendor competencies by segment?
• What are the major strategies adopted by leading market companies?
• What are company challenges and essential success factors by marketsegment?
• How company offerings and supply chain capabilitiesare shifting to meetemerging market needs?

Table  of  Contents
1.  Introduction
1.1.  Report  Description
1.2.  Market  Segmentation
1.3.  Research  Methodology
1.4.  List  of  Abbreviations
2.  Executive  Summary
3.  Market  Overview
3.1.  Market  Definition  
3.2.  Market  Scope
3.3.  Market  Drivers
3.4.  Market  Restraints
3.5.  Market  Opportunities  and  Trends
3.6.  Porter’s  five  force  analysis
3.7.  SWOT  Analysis
3.8.  PEST  Analysis
3.9.  Patent  Analysis
3.10.  Impact  of  COVID  19  on  Global  Amyotrophic  Lateral  Sclerosis  Treatment  Market
4.  Amyotrophic  Lateral  Sclerosis  Treatment  Market,  By  Treatment  ,  Market  Size  and  Forecast  2016  -2026  (USD  Million)
4.1.  Global  Amyotrophic  Lateral  Sclerosis  Treatment  Market  By  Treatment  ,  2016  -2026  (USD  Million)
4.1.1.  Global  Amyotrophic  Lateral  Sclerosis  Treatment  Market  By  Medication
4.1.2.  Global  Amyotrophic  Lateral  Sclerosis  Treatment  Market  By  Stem  Cell  Therapy  and  Others
4.2.  Global  Amyotrophic  Lateral  Sclerosis  Treatment  Market  By  Treatment    Share,  2016  -2026  (%)
5.  Amyotrophic  Lateral  Sclerosis  Treatment  Market,  By  Distribution  Channel  ,  Market  Size  and  Forecast  2016  -2026  (USD  Million)
5.1.  Global  Amyotrophic  Lateral  Sclerosis  Treatment  Market  By  Distribution  Channel  ,2016  -2026  (USD  Million)
5.1.1.  Global  Amyotrophic  Lateral  Sclerosis  Treatment  Market  By  Hospital  Pharmacies
5.1.2.  Global  Amyotrophic  Lateral  Sclerosis  Treatment  Market  By  Retail  Pharmacies  and  Others
5.2.  Global  Amyotrophic  Lateral  Sclerosis  Treatment  Market  By  Distribution  Channel    Share,  2016  -2026  (%)
6.  Amyotrophic  Lateral  Sclerosis  Treatment  Market,  By  Region  Market  Size  and  Forecast  2016  -2026
6.1.  NORTH  AMERICA
6.1.1.  Key  Findings
6.1.2.  Impact  of  COVID  19
6.1.3.  Key  market  trends,  growth  factors  and  opportunities
6.1.4.  North  America  Amyotrophic  Lateral  Sclerosis  Treatment  Market  by  Country  2016  -2026  (USD  Million)
6.1.5.  North  America  Amyotrophic  Lateral  Sclerosis  Treatment  Market  By  Treatment  2016  -2026  (USD  Million)
6.1.6.  North  America  Amyotrophic  Lateral  Sclerosis  Treatment  Market  By  Distribution  Channel    2016  -2026  (USD  Million)
6.2.  EUROPE
6.2.1.  Key  Findings
6.2.2.  Impact  of  COVID  19
6.2.3.  Key  market  trends,  growth  factors  and  opportunities
6.2.4.  Europe  Amyotrophic  Lateral  Sclerosis  Treatment  Market  by  Country  2016  -2026  (USD  Million)
6.2.5.  Europe  Amyotrophic  Lateral  Sclerosis  Treatment  Market  By  Treatment    2016  -2026  (USD  Million)
6.2.6.  Europe  Amyotrophic  Lateral  Sclerosis  Treatment  Market  By  Distribution  Channel    2016  -2026  (USD  Million)
6.3.  ASIA  PACIFIC
6.3.1.  Key  Findings
6.3.2.  Impact  of  COVID  19
6.3.3.  Key  market  trends,  growth  factors  and  opportunities
6.3.4.  Asia  Pacific  Amyotrophic  Lateral  Sclerosis  Treatment  Market  by  Country  2016  -2026  (USD  Million)
6.3.5.  Asia  Pacific  Amyotrophic  Lateral  Sclerosis  Treatment  Market  By  Treatment    2016  -2026  (USD  Million)
6.3.6.  Asia  Pacific  Amyotrophic  Lateral  Sclerosis  Treatment  Market  By  Distribution  Channel    2016  -2026  (USD  Million)
6.4.  LATIN  AMERICA
6.4.1.  Key  Findings
6.4.2.  Impact  of  COVID  19
6.4.3.  Key  market  trends,  growth  factors  and  opportunities
6.4.4.  Latin  America  Amyotrophic  Lateral  Sclerosis  Treatment  Market  by  Country  2016  -2026  (USD  Million)
6.4.5.  Latin  America  Amyotrophic  Lateral  Sclerosis  Treatment  Market  By  Treatment    2016  -2026  (USD  Million)
6.4.6.  Latin  America  Amyotrophic  Lateral  Sclerosis  Treatment  Market  By  Distribution  Channel    2016  -2026  (USD  Million)
6.5.  MIDDLE  EAST  AND  AFRICA
6.5.1.  Key  Findings
6.5.2.  Impact  of  COVID  19
6.5.3.  Key  market  trends,  growth  factors  and  opportunities
6.5.4.  Middle  East  and  Africa  Amyotrophic  Lateral  Sclerosis  Treatment  Market  by  Country  2016  -2026  (USD  Million)
6.5.5.  Middle  East  and  Africa    Amyotrophic  Lateral  Sclerosis  Treatment  Market  By  Treatment    2016  -2026  (USD  Million)
6.5.6.  Middle  East  and  Africa  Amyotrophic  Lateral  Sclerosis  Treatment  Market  By  Distribution  Channel    2016  -2026  (USD  Million)
7.  Competitive  Landscape  Analysis
7.1.  Global  Amyotrophic  Lateral  Sclerosis  Treatment  Market  Company  Revenue,  (USD  Million),  2016-2019
7.2.  Global  Amyotrophic  Lateral  Sclerosis  Treatment  Market  Company  Share,  (%),  2016-2019
8.  Company  Profiles
8.1.  Mitsubishi  Tanabe  Pharma  Corporation
8.2.  Otsuka  Pharmaceutical  Co.,  Ltd.
8.3.  BrainStorm  Therapeutics,  Biogen  Inc.
8.4.  Corestem,  AB  Science
8.5.  F.Hoffmann-La  Roche  AG
8.6.  Biohaven  Pharmaceutical
8.7.  Sun  Pharmaceutical
8.8.  Ionis  Pharmaceuticals,  Inc.  
8.9.  Mitsubishi  Tanabe  Pharma  Corporation  
8.10.  Others  

9.  Appendix
10.  List  of  Tables  
11.  List  of  Figures  


 Feel free to contact us

 
Choose License Type
Select User Type


Report code




x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT